If you need more lookups,
subscriptions start at $34 USD/month.
Andreas Claas Location
Cambridge, GB
Andreas Claas Work
2026 -now CTO and Co-founder @
2024 -2026 CSO and Co-founder @
2022 -2023 RNA Development @ VaxEquity Ltd
2021 -2022 Principal Scientist and Labcorp, CMC Genomics @
2019 -2021 Principal Scientist and Covance, CMC Genomics @
2017 -2019 Principal Scientist and CMC R and D @
2014 -2016 Senior Development Scientist and Senior Project Manager, R and D @
2014 -2014 Molecular Biologist (R and D) @
2005 -2013 Senior Scientific Officer (R and D) @
2002 -2005 Postdoctoral Research Fellow @
2002 -2002 Postdoc @
2001 -2001 Postdoc @
1995 -2001 PhD student @
1994 -1995 Master's thesis - Microbiology @
Andreas Claas Education
DKFZ German Cancer Research Center 1994-2001
University of Münster 1989-1994
Andreas Claas Skills
Leadership
Molecular Cytogenetics
Biotech R&D
Molekularbiologie
qPCR
Sequenzierung
Cell Biology
ELISA
Zellbiologie
Consultancy
Recombinant Antibodies
Biochemie
Genomics
Transfektion
Business Development
Biotechnologie
PCR
Biotechnology
Wissenschaft
DNA
Life Sciences
Cell Culture
Protein Engineering
Strategic Planning
Krebsforschung
Forschung und Entwicklung
Molecular Biology
Biowissenschaften
Mikrobiologie
Protein Expression
Next Generation Sequencing
Molecular Cloning
Product Development
Project Management
Protein Purification
Genetics
Research
Dna Sequenzierung
Genomik
Science
Genetik
Biomarker Discovery
Andreas Claas Summary
Andreas Claas, based in Cambridge, GB, is currently a CTO and Co-founder at Cambridge Medixine Ltd.. Andreas Claas brings experience from previous roles at Cambridge Medixine Ltd., VaxEquity Ltd and Labcorp Drug Development. Andreas Claas holds a 1994 - 2001 DKFZ German Cancer Research Center. With a robust skill set that includes Leadership, Molecular Cytogenetics, Biotech R&D, Molekularbiologie, qPCR and more. Andreas Claas has 2 emails on RocketReach.
Looking for a different Andreas Claas?
Find contact details for 700 million professionals.